These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38360812)

  • 1. Farnesoid X receptor promotes non-small cell lung cancer metastasis by activating Jak2/STAT3 signaling via transactivation of IL-6ST and IL-6 genes.
    Jin X; Shang B; Wang J; Sun J; Li J; Liang B; Wang X; Su L; You W; Jiang S
    Cell Death Dis; 2024 Feb; 15(2):148. PubMed ID: 38360812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OGT regulated O-GlcNacylation promotes migration and invasion by activating IL-6/STAT3 signaling in NSCLC cells.
    Ge X; Peng X; Li M; Ji F; Chen J; Zhang D
    Pathol Res Pract; 2021 Sep; 225():153580. PubMed ID: 34391182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The FXR Agonist, Obeticholic Acid, Suppresses HCC Proliferation & Metastasis: Role of IL-6/STAT3 Signalling Pathway.
    Attia YM; Tawfiq RA; Ali AA; Elmazar MM
    Sci Rep; 2017 Oct; 7(1):12502. PubMed ID: 28970500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aryl hydrocarbon receptor mediates Jak2/STAT3 signaling for non-small cell lung cancer stem cell maintenance.
    Xiong J; Zhang X; Zhang Y; Wu B; Fang L; Wang N; Yi H; Chang N; Chen L; Zhang J
    Exp Cell Res; 2020 Nov; 396(1):112288. PubMed ID: 32941808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-17 induces NSCLC cell migration and invasion by elevating MMP19 gene transcription and expression through the interaction of p300-dependent STAT3-K631 acetylation and its Y705-phosphorylation.
    Ge W; Li YA; Ruan Y; Wu N; Ma P; Xu T; Shu Y; Wang Y; Qiu W; Zhao C
    Oncol Res; 2024; 32(4):625-641. PubMed ID: 38560562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Farnesoid X receptor, a novel proto-oncogene in non-small cell lung cancer, promotes tumor growth via directly transactivating CCND1.
    You W; Chen B; Liu X; Xue S; Qin H; Jiang H
    Sci Rep; 2017 Apr; 7(1):591. PubMed ID: 28377627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AKR1C1 Activates STAT3 to Promote the Metastasis of Non-Small Cell Lung Cancer.
    Zhu H; Chang LL; Yan FJ; Hu Y; Zeng CM; Zhou TY; Yuan T; Ying MD; Cao J; He QJ; Yang B
    Theranostics; 2018; 8(3):676-692. PubMed ID: 29344298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The membrane bile acid receptor TGR5 drives cell growth and migration via activation of the JAK2/STAT3 signaling pathway in non-small cell lung cancer.
    Liu X; Chen B; You W; Xue S; Qin H; Jiang H
    Cancer Lett; 2018 Jan; 412():194-207. PubMed ID: 29074425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypermethylated in cancer 1(HIC1) suppresses non-small cell lung cancer progression by targeting interleukin-6/Stat3 pathway.
    Wang X; Wang Y; Xiao G; Wang J; Zu L; Hao M; Sun X; Fu Y; Hu G; Wang J
    Oncotarget; 2016 May; 7(21):30350-64. PubMed ID: 27107418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA SNHG3 is activated by E2F1 and promotes proliferation and migration of non-small-cell lung cancer cells through activating TGF-β pathway and IL-6/JAK2/STAT3 pathway.
    Shi J; Li J; Yang S; Hu X; Chen J; Feng J; Shi T; He Y; Mei Z; He W; Xie J; Li S; Jie Z; Tu S
    J Cell Physiol; 2020 Mar; 235(3):2891-2900. PubMed ID: 31602642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.
    Chen J; Lan T; Zhang W; Dong L; Kang N; Zhang S; Fu M; Liu B; Liu K; Zhan Q
    Cancer Res; 2015 Oct; 75(19):4198-210. PubMed ID: 26359459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-22 promotes lung cancer cell proliferation and migration via the IL-22R1/STAT3 and IL-22R1/AKT signaling pathways.
    Bi Y; Cao J; Jin S; Lv L; Qi L; Liu F; Geng J; Yu Y
    Mol Cell Biochem; 2016 Apr; 415(1-2):1-11. PubMed ID: 26983629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-37 inhibits invasion and metastasis in non-small cell lung cancer by suppressing the IL-6/STAT3 signaling pathway.
    Jiang M; Wang Y; Zhang H; Ji Y; Zhao P; Sun R; Zhang C
    Thorac Cancer; 2018 May; 9(5):621-629. PubMed ID: 29575809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reciprocal activation between IL-6/STAT3 and NOX4/Akt signalings promotes proliferation and survival of non-small cell lung cancer cells.
    Li J; Lan T; Zhang C; Zeng C; Hou J; Yang Z; Zhang M; Liu J; Liu B
    Oncotarget; 2015 Jan; 6(2):1031-48. PubMed ID: 25504436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-17 promoted metastasis of non-small-cell lung cancer cells.
    Li Q; Han Y; Fei G; Guo Z; Ren T; Liu Z
    Immunol Lett; 2012 Dec; 148(2):144-50. PubMed ID: 23089548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of IL-6 and JAK2/STAT3 signaling pathway with prognosis of nasopharyngeal carcinoma patients.
    Zhuang M; Ding X; Song W; Chen H; Guan H; Yu Y; Zhang Z; Dong X
    Aging (Albany NY); 2021 Jun; 13(12):16667-16683. PubMed ID: 34165442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gankyrin promotes epithelial-mesenchymal transition and metastasis in NSCLC through forming a closed circle with IL-6/ STAT3 and TGF-β/SMAD3 signaling pathway.
    Wang WP; Sun Y; Lu Q; Zhao JB; Wang XJ; Chen Z; Ni YF; Wang JZ; Han Y; Zhang ZP; Yan XL; Li XF
    Oncotarget; 2017 Jan; 8(4):5909-5923. PubMed ID: 27992365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APE1 shRNA-loaded cancer stem cell-derived extracellular vesicles reverse Erlotinib resistance in non-small cell lung cancer via the IL-6/STAT3 signalling.
    Tang CH; Qin L; Gao YC; Chen TY; Xu K; Liu T; Ren T
    Clin Transl Med; 2022 May; 12(5):e876. PubMed ID: 35605028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-X-C chemokine receptor 2 correlates with unfavorable prognosis and facilitates malignant cell activities via activating JAK2/STAT3 pathway in non-small cell lung cancer.
    Wei L; Liu Y; Ma Y; Ding C; Zhang H; Lu Z; Gu Z; Zhu C
    Cell Cycle; 2019 Dec; 18(24):3456-3471. PubMed ID: 31731888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling.
    Zhu F; Dai C; Fu Y; Loo JF; Xia D; Gao SP; Ma Z; Chen Z
    Oncotarget; 2016 Feb; 7(8):9462-76. PubMed ID: 26843613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.